We are live on ! Find out more
NV

Northpond Ventures Portfolio holdings

AUM $43.7M
1-Year Est. Return 27.27%
This Fund
S&P 500
This Quarter Est. Return
-41.77%
1 Year Est. Return
-27.27%
3 Year Est. Return
-67.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$186M
AUM Growth
-$100M
Cap. Flow
+$55.6M
Cap. Flow %
29.99%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
VIGL
Vigil Neuroscience
VIGL
+$55.6M
2
ISO
IsoPlexis Corporation Common Stock
ISO
+$18.9K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DICE
1
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$63M 33.95%
3,292,871
– –
TBIO
2
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$52.9M 28.49%
546,896
– –
ISO
3
DELISTED
IsoPlexis Corporation Common Stock
ISO
$30.2M 16.28%
8,808,531
+3,259
+0% +$18.9K
VIGL
4
DELISTED
Vigil Neuroscience
VIGL
$29.6M 15.97%
+4,214,498
New +$55.6M
CADL icon
5
Candel Therapeutics
CADL
$689M
$9.85M 5.31%
1,935,215
– –

Similar funds

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Northpond Ventures's Q1 2022 Portfolio in Review

As of Q1 2022, Northpond Ventures held 5 positions worth $186M, down 35% from $286M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Northpond Ventures deployed $55.6M of net new capital in Q1 2022, opening 1 new position and adding to 1 existing holding. Its largest new stake was Vigil Neuroscience: 4,214,498 shares worth $29.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Northpond Ventures's largest Q1 2022 buy was Vigil Neuroscience: 4,214,498 shares worth $29.6M.
  • Northpond Ventures added most to IsoPlexis Corporation Common Stock in Q1 2022, an estimated $18.9K increase.
  • Northpond Ventures's ten largest holdings make up 100% of its $186M portfolio in Q1 2022.
  • Northpond Ventures opened 1 new position and closed 0 in Q1 2022.
  • Northpond Ventures's portfolio value fell 35% quarter-over-quarter to $186M.

Based on Northpond Ventures's 13F filing for Q1 2022, filed 16 May 2022.